title: Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.
authors.forename: W
authors.initials: W
authors.lastname: Henle
authors.forename: G
authors.initials: G
authors.lastname: Henle
authors.forename: H C
authors.initials: HC
authors.lastname: Ho
authors.forename: P
authors.initials: P
authors.lastname: Burtin
authors.forename: Y
authors.initials: Y
authors.lastname: Cachin
authors.forename: P
authors.initials: P
authors.lastname: Clifford
authors.forename: A
authors.initials: A
authors.lastname: de Schryver
authors.forename: G
authors.initials: G
authors.lastname: de-Thé
authors.forename: V
authors.initials: V
authors.lastname: Diehl
authors.forename: G
authors.initials: G
authors.lastname: Klein
mesh_terms: D000351:Africa, Eastern; D000914:Antibodies, Viral / Q000302:isolation & purification*; D002277:Carcinoma / Q000473:pathology / Q000821:virology*; D016022:Case-Control Studies; D019084:Fluorescent Antibody Technique, Indirect; D005602:France; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000821:virology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006723:Hong Kong; D006801:Humans; D007194:India; D009303:Nasopharyngeal Neoplasms / Q000473:pathology / Q000821:virology*
chemical_list: D000914:Antibodies, Viral